Literature DB >> 34602772

Boutique Egg Freezing: Empowering Technology or Marketing Phenomenon? A Word of Caution.

Shruti Agarwal1, Mark P Trolice1,2, Jody Lyneé Madeira3, Steven R Lindheim4,5.   

Abstract

The introduction of oocyte vitrification has propelled the field of oncofertility. However, it is becoming increasingly common to offer planned oocyte cryopreservation to healthy, fertile women due to a lack of a partner or other personal issues. The aim of this article is to discuss the pros and cons of planned oocyte cryopreservation along with potential exploitation issues by unregulated clinics and international agencies. This article further encourages obstetricians and gynecologists to discuss these issues of planned oocyte cryopreservation with their patients to empower them to make an educated decision based on research and science rather than be susceptible to entities that stand to gain monetarily by prompting women to fear a childless future. © Federation of Obstetric & Gynecological Societies of India 2021.

Entities:  

Keywords:  Boutique egg freezing; Oocyte cryopreservation; Social egg freezing

Year:  2021        PMID: 34602772      PMCID: PMC8440716          DOI: 10.1007/s13224-021-01528-4

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  3 in total

Review 1.  Elective egg freezing without medical indications.

Authors:  Alessandra Alteri; Valerio Pisaturo; Daniela Nogueira; Arianna D'Angelo
Journal:  Acta Obstet Gynecol Scand       Date:  2019-03-05       Impact factor: 3.636

2.  Mature oocyte cryopreservation: a guideline.

Authors: 
Journal:  Fertil Steril       Date:  2012-10-22       Impact factor: 7.329

Review 3.  Cross border reproductive care (CBRC): a growing global phenomenon with multidimensional implications (a systematic and critical review).

Authors:  Mahmoud Salama; Vladimir Isachenko; Evgenia Isachenko; Gohar Rahimi; Peter Mallmann; Lynn M Westphal; Marcia C Inhorn; Pasquale Patrizio
Journal:  J Assist Reprod Genet       Date:  2018-05-28       Impact factor: 3.412

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.